Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Nature Genetics
|
April 25, 2018
Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma
Ana C deCarvalho, Hoon Kim, Laila M Poisson, et al.
NPJ Precision Oncology
|
November 13, 2018
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways
Sameer H Halani, Safoora Yousefi, Jose Velazquez Vega, et al.
Neuro-Oncology
|
February 25, 2021
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features
Maritza S Mosella, Thais S Sabedot, Tiago C Silva, et al.
Neuro-Oncology
|
February 9, 2021
A serum-based DNA methylation assay provides accurate detection of glioma
Thais S Sabedot, Tathiane M Malta, James Snyder, et al.
Nature
|
February 13, 2009
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, et al.
European Urology
|
June 12, 2010
Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, et al.
AJNR. American Journal of Neuroradiology
|
April 29, 2024
Sex-Specific Differences in Patients with <i>IDH1</i>-Wild-Type Grade 4 Glioma in the ReSPOND Consortium
Sree Gongala, Jose A Garcia, Nisha Korakavi, et al.
Neuro-Oncology
|
February 25, 2022
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors
Grayson A Herrgott, Karam P Asmaro, Michael Wells, et al.
Neuroradiology
|
July 19, 2023
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium
Matthew D Lee, Sohil H Patel, Suyash Mohan, et al.
Neuro-Oncology
|
March 11, 2020
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium
Christos Davatzikos, Jill S Barnholtz-Sloan, Spyridon Bakas, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Nature Genetics
|
April 25, 2018
Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma
Ana C deCarvalho, Hoon Kim, Laila M Poisson, et al.
NPJ Precision Oncology
|
November 13, 2018
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways
Sameer H Halani, Safoora Yousefi, Jose Velazquez Vega, et al.
Neuro-Oncology
|
February 25, 2021
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features
Maritza S Mosella, Thais S Sabedot, Tiago C Silva, et al.
Neuro-Oncology
|
February 9, 2021
A serum-based DNA methylation assay provides accurate detection of glioma
Thais S Sabedot, Tathiane M Malta, James Snyder, et al.
Nature
|
February 13, 2009
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, et al.
European Urology
|
June 12, 2010
Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, et al.
AJNR. American Journal of Neuroradiology
|
April 29, 2024
Sex-Specific Differences in Patients with <i>IDH1</i>-Wild-Type Grade 4 Glioma in the ReSPOND Consortium
Sree Gongala, Jose A Garcia, Nisha Korakavi, et al.
Neuro-Oncology
|
February 25, 2022
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors
Grayson A Herrgott, Karam P Asmaro, Michael Wells, et al.
Neuroradiology
|
July 19, 2023
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium
Matthew D Lee, Sohil H Patel, Suyash Mohan, et al.
Neuro-Oncology
|
March 11, 2020
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium
Christos Davatzikos, Jill S Barnholtz-Sloan, Spyridon Bakas, et al.
Page
of 7